Hsien-Yen Chang, PhD
Center & Institute Affiliation(s):
Hampton House 682
Baltimore , Maryland
PhD , 2008
Risk adjustment and its applications
Overuse measurements and their applications
Outcome evaluation and cost-effectiveness analysis
Honors and Awards
Phi Beta Kappa Honor Society, 2009-Present
Taiwan Merits Scholarships, 2005–2008
Rotary Foundation Academic-Year Ambassadorial Scholar, 2001–2002
Chang HY, Zhou M, Tang W, et al. Risk of gastrointestinal bleedings associated with oral anticoagulants – a population-based retrospective cohort study. BMJ. 2015;350:h1585.
Chang HY, Bodycombe D, Huang WF, Weiner JP. Risk-Adjusted Resource Allocation: Using Taiwan’s National Health Insurance as an Example. Asia Pac J Public Health. 2015;27(2):NP958-71.
Chang HY, Clark JM, Weiner JP. Morbidity Trajectories as Predictors of Utilization: Multi-Year Disease Patterns in Taiwan's National Health Insurance Program. Med Care. 2011 Oct;49(10):918-23.
Singh S, Chang HY, Richards T, et al. Glucagonlike Peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus. JAMA Intern Med. 2013 Apr 8;173(7):534-9.
Hwang CS, Chang HY, Alexander GC. Impact of abuse-deterrent OxyContin on prescription opioid utilization. Pharmacoepidemiol Drug Saf. 2015 Feb 13;24(2):197-204.